Table 2 Cumulative incidence of clinical outcomes
From: Effects of metabolic parameters’ variability on cardiovascular outcomes in diabetic patients
SBP CV | TC CV | TG CV | Glucose CV | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low | High | p-value | Low | High | p-value | Low | High | p-value | Low | High | p-value | |
MACE | 279 (2.5) | 668 (6.0) | < 0.01 | 337 (3.0) | 610 (5.5) | < 0.01 | 425 (3.8) | 522 (4.7) | < 0.01 | 305 (2.7) | 642 (5.8) | < 0.01 |
MI | 239 (2.1) | 549 (4.9) | < 0.01 | 286 (2.6) | 502 (4.5) | < 0.01 | 351 (3.2) | 437 (3.9) | < 0.01 | 252 (2.3) | 536 (4.8) | < 0.01 |
Stroke | 39 (0.4) | 132 (1.2) | < 0.01 | 51 (0.5) | 120 (1.1) | < 0.01 | 79 (0.7) | 92 (0.8) | 0.32 | 52 (0.5) | 119 (1.1) | < 0.01 |
CVD | 6 (0.05) | 18 (0.2) | 0.01 | 9 (0.1) | 15 (0.1) | 0.22 | 13 (0.1) | 11 (0.1) | 0.68 | 9 (0.1) | 15 (0.1) | 0.22 |